In 10 seconds? Scientists are making advancements in increasing the potential of an emerging anti-cancer therapy, the use of 'oncolytic viruses'. A 2021 review paper details how the potential of such viruses can be increas...
In 10 seconds? Researchers have found a way to target and kill hard-to-reach cancerous tumor cells through enhanced technology that harnesses a patient's own immune cells. The discovery expands the curative potential of immuno...
In 10 seconds? Researchers have found novel structures near brain tumours that can be used to provoke an immune response against cancer cells. This could open the way for more effective treatment with fewer side effects in the fut...
In 10 seconds? Scientists have pinpointed a potential cause for the side-effects of a type of immunotherapy called immune checkpoint blockade. This is an important step in overcoming adverse events associated with this cancer trea...
Scientists have managed to extend the lives of drug-resistant ovarian cancer patients through a combination therapy and discovered other ways to attack the stubborn disease. In 10 seconds? Scientists shrunk the tumours in women s...
A gene known for destroying hair cells can significantly improve treatment for melanoma and is a good candidate to help with prostate cancer. The discovery further highlights the potential of immunotherapy in targeting tumours. I...
London researchers have developed a three-pronged strategy to tackle pancreatic cancer by combining a drug and viruses that target cancer cells with immune cells from the patients, modified to specifically attack pancreatic cancer...
By opening a way for the immune system to attack tumours, two scientists revolutionised cancer care and won a Nobel Prize in 2018. Here is why their discoveries matter and how patients are already feeling the benefits. In 10 seco...
Beware, cancer! Thanks to a newly developed technology we are gaining insights into how immune cells can spot cancer cells that try to play hide and seek. This achievement is an important step in making anti-tumour immunotherapy m...